Loading the player...
Information
ATA Surgical Symposium
Accreditation
The American Thyroid Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA PRA Category 1 Credits™
The American Thyroid Association designates this enduring activity for a maximum of 2.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Information
In accordance with the ACCME Accreditation Criteria, the American Thyroid Association ensures that anyone in a position to control the content of the educational activity (planners/speakers/authors/discussants/moderators) disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”) held in the last 24 months.
The ACCME also requires that ATA manage any reported relevant financial relationships and eliminate the potential for bias during the educational activity. Any relevant financial relationships noted have been mitigated. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.
Elizabeth Cottrill – Nothing to disclose
Abbey Fingeret – Nothing to disclose
Michael Singer – Nothing to disclose
Toni Beninato – Nothing to disclose
Heather Wachtel – Nothing to disclose
Andrew Rosko - Nothing to disclose
F. Thurston Drake – Pfizer (Speaker); Corcept Therapeutics (Individual Stocks)
Amanda Silver-Karcioglu – Nothing to disclose
Elizabeth Cottrill, MD
No financial disclosures.
Abbey Fingeret, MD
No financial disclosures.
Michael Carmi Singer, MD
Michael Carmi Singer, MD is the Director of the Division of Thyroid & Parathyroid Surgery at the Henry Ford Health System in Detroit, Michigan. Dr. Singer completed a fellowship in head and neck endocrine surgery at the Medical College of Georgia. A second fellowship in minimally invasive endocrine surgery augmented his experience with minimally invasive, endoscopic and robotic endocrine techniques. Dr. Singer’s practice is dedicated exclusively to the surgical management of thyroid and parathyroid diseases. He has published extensively on improving endocrine surgery outcomes and facilitating minimally invasive and robotic surgery. His research efforts are focused on surgical innovation and the development of surgical technology.
